SARs and QSARs of mutagens and carcinogens: Understanding action mechanisms and improving risk assessment

Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens

Volumn , Issue , 2003, Pages 259-282

  Benigni, Romualdo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85041427248     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203010822     Document Type: Chapter

References (71)

1. Hansch, C., Quantitative structure-activity relationships and the unnamed science, Acc. Chem. Res., 26, 147, 1993.
2. Arcos, J.C. and Argus, M.F., Multifactor interaction network of carcinogenesis: a “tour guide”, in Chemical Induction of Cancer: Modulation and Combination Effects, Arcos, J.C., Argus, M.F., Woo, Y.T., Eds., Birkhauser, Boston, 1995, p. 1.
3. Woo, Y.-T., Mechanisms of action of chemical carcinogens, and their role in structure- activity relationship (SAR) analysis and risk assessment, in Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens, Benigni, R., Ed., CRC Press, Boca Raton, FL, 2003.
4. Miller, J.A. and Miller, E.C., Ultimate chemical carcinogens as reactive mutagenic electrophiles, in Origins of Human Cancer, Hiatt, H.H., Watson, J.D., and Winsten, J.A., Eds., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1977, p. 605.
5. Ashby, J., Fundamental structural alerts to potential carcinogenicity or non-carcinogenicity, Environ. Mutagen., 7, 919, 1995.
6. Woo, Y.-T., et al., Development of structure-activity relationship rules for predicting carcinogenic potential of chemicals, Toxicol. Lett., 79, 219, 1995.
7. Woo, Y.-T., et al., Use of mechanism-based structure-activity relationships analysis in carcinogenic potential ranking for drinking water disinfection by-products, Environ. Health Perspect., 110, 75, 2002.
8. Benigni, R. and Richard, A.M., Quantitative structure-based modeling applied to characterization and prediction of chemical toxicity, Methods, 14, 264, 1998.
9. Benigni, R. et al., QSAR models for discriminating between mutagenic and nonmutagenic aromatic and heteroaromatic amines, Environ. Mol. Mutagen., 32, 75, 1998.
10. Tomatis, L. et al., Avoided and avoidable risks of cancer, Carcinogenesis, 18, 97, 1997.
11. Huff, J.E., Haseman, J.K., and Rall, D.P., Scientific concepts, value, and significance of chemical carcinogenesis studies, Annu. Rev. Pharmacol. Toxicol., 31, 621, 1991.
12. Gold, L.S. et al., The carcinogenic potency database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program, Environ. Health Perspect., 96, 11, 1991.
13. Huff, J., Chemicals and cancer in humans: first evidence in experimental animals, Environ. Health Perspect., 100, 201, 1993.
14. Huff, J., Value, validity, and historical development of carcinogenesis studies for predicting and confirming carcinogenic risks to humans, in Carcinogenicity: Testing, Predicting, and Interpreting Chemical Effects., Kitchin, K.T., Ed., Marcel Dekker, New York, 1999, p. 21.
15. Huff, J., Long-term chemical carcinogenesis bioassays predict human cancer hazards: issues, controversies, and uncertainties, Ann. N.Y. Acad. Sci., 895, 56, 1999.
16. Benigni, R. and Giuliani, A., Tumor profiles and carcinogenic potency in rodents and humans: value for cancer risk assessment, Environ. Carcino. Ecotoxicol. Rev., C17, 45, 1999.
17. Allen, B.C., Crump, K.S., and Shipp, A.M., Correlation between carcinogenic potency of chemicals in animals and humans, Risk Anal., 8, 531, 1988.
18. Goodman, G. and Wilson, R., Quantitative prediction of human cancer risk from rodent carcinogenic potencies: a closer look at the epidemiological evidence for some chemicals not definitively carcinogenic in humans, Regulat. Pharmacol. Toxicol., 14, 118, 1991.
19. Bucci, T.J., Profiles of induced tumors in animals, Toxicol. Pathol., 13, 105, 1985.
20. Benigni, R. and Pino, A., Profiles of chemically-induced tumors in rodents: quantitative relationships. Mutat. Res., 421, 93, 1998.
21. Franke, R. et al., Prediction of rodent carcinogenicity of aromatic amines: a quantitative structure-activity relationships model, Carcinogenesis, 22, 1561, 2001.
22. Haseman, J.K. et al., Carcinogenesis bioassays: study duration and biological relevance, Food Chem. Toxicol., 39, 739, 2001.
23. Benigni, R. and Giuliani, A., Quantitative structure-activity relationship (QSAR) studies of mutagens and carcinogens, Med. Res. Rev., 16, 267, 1996.
24. Cronin, M.T.D. and Dearden, J.C., QSAR in toxicology. 3. Prediction of chronic toxicities, Quant. Struct.-Act. Relat., 14, 329, 1995.
25. Debnath, A.K. et al., The importance of the hydrophobic interaction in the mutagenicity of organic compounds, Mutat. Res., 305, 63, 1994.
26. Hansch, C., Structure-activity relationships of chemical mutagens and carcinogens, Sci. Tot. Environ., 109/110, 17, 1991.
27. Passerini, L., QSARs for individual classes of chemical mutagens and carcinogens, in Quantitative Structure-Activity Relationship (QSAR) Models for Mutagens and Carcinogens, Benigni, R., Ed., CRC Press, Boca Raton, FL, 2003.
28. Hansch, C. et al., Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms, Chem. Rev., 101, 619, 2001.
29. Hansch, C. et al., Chem-bioinformatics: comparative QSAR at the interface between chemistry and biology, Chem. Rev., 102, 783, 2002.
30. Benigni, R. and Passerini, L., Carcinogenicity of the aromatic amines: from structure- activity relationships to mechanisms of action and risk assessment, Mutat. Res. Rev., 511, 191, 2002.
31. McCutcheon, P., Implications of council regulation 793/93 on the evaluation and control of existing substances, Ann. Ist. Super. Sanità, 30, 367, 1994.
32. Cronin, M.T.D. and Dearden, J.C., QSAR in toxicology. 4. Prediction of non-lethal mammalian toxicological end points, and expert systems for toxicity prediction, Quant. Struct.-Act. Relat., 14, 518, 1995.
33. Dearden, J.C. et al., The development and validation of expert systems for predicting toxicity, Alternative to Laboratory Animals (ATLA), 25, 223, 1997.
34. Richard, A.M. and Benigni, R., AI and SAR approaches for predicting chemical carcinogenicity: survey and status report, SAR QSAR Environ. Res., 13, 1, 2002.
35. Tennant, R.W. et al., Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 chemicals by the National Toxicology Program, Mutagenesis, 5, 3, 1990.
36. Bristol, D.W., Wachsman, J.T., and Greenwell, A., The NIEHS predictive-toxicology evaluation project: chemcarcinogenicity biossay, Environ. Health Perspect., 104, 1001, 1996.
37. Jones, J.D. and Easterly, C.E., On the rodent bioassays currently being conducted on 44 chemicals: a RASH analysis to predict test results from the National Toxicology Program, Mutagenesis, 6, 507, 1991.
38. Rosenkranz, H.S. and Klopman, G., Prediction of the carcinogenicity in rodents of chemicals currently being tested by the U.S. National Toxicology Program: structure- activity correlations, Mutagenesis, 5, 425, 1990.
39. Enslein, K., Blake, B.W., and Borgstedt, H.H., Prediction of probability of carcinogenicity for a set of ongoing NTP bioassays, Mutagenesis, 5, 305, 1990.
40. Lewis, D.F.V., Ionnides, C., and Parke, D.V., A prospective toxicity evalution (COMPACT) on 40 chemicals currently being tested by the National Toxicology Program, Mutagenesis, 5, 433, 1990.
41. Sanderson, D.M. and Earnshaw, C.G., Computer prediction of possible toxic action from chemical structure: the DEREK system, Hum. Exp. Toxicol., 10, 261, 1991.
42. Bakale, G. and McCreary, R.D., Prospective Ke screening of potential carcinogens being tested in rodent bioassay by the U.S. National Toxicology Program, Mutagenesis, 7, 91, 1992.
43. Benigni, R., QSAR prediction of rodent carcinogenicity for a set of chemicals currently bioassayed by the U.S. National Toxicology Program, Mutagenesis, 19, 83, 1991.
44. Benigni, R. et al., Electrophilicity as measured by Ke: molecular determinants, relationship with other physical chemical and quantum mechanical parameters, and ability to predict rodent carcinogenicity, Carcinogenesis, 13, 547, 1992.
45. Anon., Predicting Chemical Carcinogenesis in Rodents: An International Workshop, National Institute of Environmental Health Sciences, Research Triangle Park, NC, 1993.
46. Benigni, R., The first U.S. National Toxicology Program exercise on the prediction of rodent carcinogenicity: definitive results, Mutat. Res., 387, 35, 1997.
47. Provost, F. and Fawcett, T., Robust classification for imprecise environment, Machine Learn. J., 42, 5, 2001.
48. Benigni, R., Structure-activity relationships in mutagenesis and carcinogenesis, in Progress in the Reduction, Refinement and Replacement of Animal Experimentation, Balls, M., van Zeller, A.M., and Halder, M.E., Eds., Elsevier Science, Amsterdam, 2000, p. 469.
49. Woo, Y.T. et al., Mechanism-based structure-activity relationship (SAR) analysis of carcinogenic potential of 30 NTP test chemicals, Environ. Carcino. Ecotoxicol. Rev., C15, 139, 1997.
50. Huff, J., Weisburger, E., and Fung, V.A., Multiconponent criteria for predicting carcinogenicity: dataset of 30 NTP chemicals, Environ. Health Perspect., 104, 1105, 1996.
51. Benigni, R., Andreoli, C., and Zito, R., Prediction of the carcinogenicity of further 30 chemicals biossayed by the U.S. National Toxicology Program, Environ. Health Perspect., 104, 1041, 1996.
52. Tennant, R.W. and Spalding, J., Predictions for the outcome of rodent carcinogenicity biossays: identification of trans-species carcinogens and noncarcinogens, Environ. Health Perspect., 104, 1095, 1996.
53. Ashby, J., Prediction of rodent carcinogenicity for 30 chemicals, Environ. Health Perspect., 104, 1101, 1996.
54. Moriguchi, I., Hirano, H., and Hirono, S., Prediction of the rodent carcinogenicity of organic compounds from their chemical structures using the FALS method, Environ. Health Perspect., 104, 1051, 1996.
55. Bootman, J., Speculations on the rodent carcinogenicity of 30 chemicals currently under evaluation in rat and mouse bioassays organised by the U.S. National Toxicology Program, Environ. Mol. Mutagen., 27, 237, 1996.
56. Jones, T.D. and Easterly, C.E., A RASH analysis of National Toxicity Program data: predictions for 30 compounds to be tested in rodent carcinogenesis experiments, Environ. Health Perspect., 104, 1017, 1996.
57. Kerckaert, G.A. et al., Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent biossays, Environ. Health Perspect., 104, 1075, 1996.
58. Lee, Y., Buchanan, B.G., and Rosenkranz, H.S., Carcinogenicity predictions for a group of 30 chemicals undergoing rodent cancer biossays based on rules derived from subchronic organic toxicities, Environ. Health Perspect., 104, 1059, 1996.
59. Zhang, Y.P. et al., Prediction of the carcinogenicity of a second group of organic chemicals undergoing carcinogenicity testing, Environ. Health Perspect., 104, 1045, 1996.
60. King, R.D. and Srinivasan, A., Prediction of rodent carcinogenicity biossays from molecular structure using inductive logic programming, Environ. Health Perspect., 104, 1031, 1996.
61. Marchant, C.A., Prediction of rodent carcinogenicity using the DEREK system for 30 chemicals currently being tested by the National Toxicology Program, Environ. Health Perspect., 104, 1065, 1996.
62. Purdy, R., A Mechanism-mediated model for carcinogenicity: model content and prediction of the outcome of rodent carcinogenicity biossays currently being conducted on 25 organic chemicals, Environ. Health Perspect., 104, 1085, 1996.
63. Lewis, D.F.V., Ioannides, C., and Parke, D.V., COMPACT and molecular structure in toxicity assessment: a prospective evaluation of 30 chemicals currently being tested for rodent carcinogenicity by the NCI/NTP, Environ. Health Perspect., 104, 1011, 1996.
64. Zhang, L. et al., The structure-activity relationships of skin carcinogenicity of aromatic hydrocarbons and heterocycles, Chem. Biol. Interact., 81, 149, 1992.
65. Benigni, R. et al. Quantitative structure-activity relationships of mutagenic and carcinogenic aromatic amines, Chem. Rev., 100, 3697, 2000.
66. Benigni, R. and Richard, A.M., QSARs of mutagens and carcinogens: two case studies illustrating problems in the construction of models for noncongeneric chemicals, Mutat. Res., 371, 29, 1996.
67. Fung, V.A., Barrett, J.C., and Huff, J., The carcinogenesis biossay in perspective: application in identifying human cancer hazards, Environ. Health Perspect., 103, 680, 1995.
68. Soffritti, M. et al., Mega-experiments to identify and assess diffuse carcinogenic risks, Ann. N.Y. Acad. Sci., 895, 34, 1999.
69. Golbraikh, A. and Tropsha, A., Beware of q2!, J. Mol. Graph. Model., 20, 269, 2002.
70. Matthews, E.J. and Contrera, J.F., A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSARES software, Regulat. Pharmacol. Toxicol., 28, 242, 1998.
71. Contrera, J.F., Jacobs, A.C., and DeGeorge, J.J., Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals, Regulat. Pharmacol. Toxicol., 25, 130, 1997.